Sage Therapeutics (SAGE) Earnings Date & Reports

A.I. Advisor
published Earnings

SAGE is expected to report earnings to fall 9.44% to -162 cents per share on July 31

Sage Therapeutics SAGE Stock Earnings Reports
Q2'24
Est.
$-1.63
Q1'24
Missed
by $0.15
Q4'23
Beat
by $0.73
Q3'23
Missed
by $0.69
Q2'23
Missed
by $0.13
The last earnings report on April 25 showed earnings per share of -179 cents, missing the estimate of -164 cents. With 815.02K shares outstanding, the current market capitalization sits at 739.64M.
View a ticker or compare two or three
SAGE
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com